Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02958462 · ClinicalTrials.gov registry record · NA
Pre-myeloid Cancer and Bone Marrow Failure Clinic Study
A NA study of Hematopoietic and Lymphatic System Neoplasm and Hematologic Neoplasms, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 2,000
- Enrollment target
- 3
- Study locations
NCT02958462 is a NA study of Hematopoietic and Lymphatic System Neoplasm and Hematologic Neoplasms that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 2,000 participants, above the 451-participant average among 62 other Hematopoietic and Lymphatic System Neoplasm trials with a reported enrollment target (343% higher). The trial reports 3 study locations across 3 states.
The verdict
NCT02958462, a NA study of Hematopoietic and Lymphatic System Neoplasm and Hematologic Neoplasms, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 2,000 participants
- Enrollment target
- 3
- Study locations
Study Summary
This clinical trial tests next generation sequencing (NGS) for the detection of precursor features of pre-myeloid cancers and bone marrow failure syndromes. NGS is a procedure that looks at relevant cancer associated genes and what they do. Finding genetic markers for pre-malignant conditions may help identify patients who are at risk of pre-myeloid cancers and bone marrow failure syndromes and lead to earlier intervention.
Conditions Studied
Interventions
- PROCEDURE Biospecimen Collection
- PROCEDURE Bone Marrow Biopsy
- PROCEDURE Buccal Swab
- OTHER Clinical Evaluation
- PROCEDURE Punch Biopsy
Study Locations (3)
Arizona
- Mayo Clinic in Arizona - Scottsdale
Florida
- Mayo Clinic in Florida - Jacksonville
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2017-01-16 |
| Est. Completion | 2035-09-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02958462
The ClinicalTrials.gov registry entry for NCT02958462 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 451-participant average among 62 other Hematopoietic and Lymphatic System Neoplasm trials with a reported enrollment target (343% higher). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Hematopoietic and Lymphatic System Neoplasm appearing as the primary indexed condition, and to 5 interventions - of which Biospecimen Collection is the first listed.
NCT02958462 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Arizona, Florida, Minnesota.
Frequently Asked Questions
What is clinical trial NCT02958462 about?
NCT02958462 is a clinical study titled "Pre-myeloid Cancer and Bone Marrow Failure Clinic Study". This clinical trial tests next generation sequencing (NGS) for the detection of precursor features of pre-myeloid cancers and bone marrow failure syndromes. NGS is a procedure that looks at relevant cancer associated genes and what they do. Finding genetic markers for pre-malignant conditions may he...
What is the current status of trial NCT02958462?
This trial is currently recruiting. It is a NA study. The enrollment target is 2,000 participants. The study started on 2017-01-16. Estimated completion is 2035-09-15.
What conditions does trial NCT02958462 study?
This clinical trial studies the following conditions: Hematopoietic and Lymphatic System Neoplasm, Hematologic Neoplasms, Cytopenia, Clonal Cytopenia of Undetermined Significance, Myeloid Malignancy.
What interventions are being tested in trial NCT02958462?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Bone Marrow Biopsy (PROCEDURE), Buccal Swab (PROCEDURE), Clinical Evaluation (OTHER), Punch Biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT02958462?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02958462 being conducted?
This trial has 3 study locations across Arizona, Florida, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hematopoietic and Lymphatic System Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Genetic Testing for the Prevention of Cancer in Indigenous American Communities (JUNIPER Trial)
RECRUITING · NA
-
Acupressure for the Reduction of Anxiety in Patients Receiving Cancer-Directed Therapy
RECRUITING · NA
-
Aromatherapy Essential Oils to Manage Anxiety and Nausea in Cancer Patients Receiving Infusion in the Ambulatory Setting
RECRUITING · NA
-
Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment
RECRUITING · NA
-
Different Types of Massage Therapy to Reduce Anxiety During Chemotherapy Infusion in Patients With Cancer
RECRUITING · NA
-
A Virtually Delivered Diet Intervention (LASO-3) for the Improvement of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors Post-treatment
RECRUITING · NA
Explore more on PlainTrial
Hematopoietic and Lymphatic System Neoplasm
All registered trials for this condition
Hematologic Neoplasms
All registered trials for this condition
Arizona
All trials with a study site in Arizona
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.